An update on the diagnosis, treatment, and prognosis of intestinal Behçet's disease
- 1 January 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 27 (1) , 24-31
Abstract
This review discusses recent scientific developments in the diagnosis, treatment, and prognosis of intestinal Behçet's disease. Gastrointestinal involvement is a major cause of morbidity and mortality in Behçet's disease. Patient clinical data are scarce because of the rarity of the disease; however, novel diagnostic criteria and disease activity indices have been developed recently to aid treatment of Behçet's disease patients. Current therapies include 5-aminosalicylic acids, corticosteroids, immunomodulators, or antitumor necrosis factor alpha agents. Antitumor necrosis factor alpha agents can achieve clinical responses and remission in patients that were previously nonresponsive to corticosteroids or immunomodulators. Clinical variables, including young age and higher disease activity at the time of diagnosis, volcano-type ulcers, absence of mucosal healing, higher C-reactive protein levels, prior history of surgery, and lack of initial response to medical therapy, can be regarded as poor prognostic factors. Previously, the diagnosis and management of intestinal Behçet's disease depended upon the expertise of individual clinicians; however, more standardized medical assessments and improved treatment regimens for Behçet's disease patients are evolving.Keywords
This publication has 45 references indexed in Scilit:
- The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodiesJournal of Gastroenterology, 2013
- Clinical Course of Intestinal Behcet’s Disease During the First Five YearsDigestive Diseases and Sciences, 2012
- Development, validation, and responsiveness of a novel disease activity index for intestinal Behcetʼs diseaseInflammatory Bowel Diseases, 2011
- Behçet’s SyndromeCurrent Rheumatology Reports, 2010
- Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet's Disease in Korean Patients With Ileocolonic UlcersAmerican Journal of Gastroenterology, 2009
- The Prevalence and Clinical Characteristics of Esophageal Involvement in Patients with Behçet's Disease: A Single Center Experience in KoreaJournal of Korean Medical Science, 2009
- Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approachJournal of Gastroenterology, 2007
- Gastrointestinal Manifestations of Behcet's DiseaseJournal of Clinical Gastroenterology, 2000
- Behçet's DiseaseSeminars in Arthritis and Rheumatism, 1998
- Behçet disease (Behçet syndrome)Seminars in Arthritis and Rheumatism, 1979